Samantha Jaglowski, MD

Publications

• Impact of chronic graft-versus-host disease on non-relapse mortality and survival.

  (Jiang J, Sigmund AM, Zhao Q, Elder P, Vasu S, Jaglowski S, Mims A, Choe H, Larkin K, Wall S, Grieselhuber N, William B, Penza S, Benson DM, Efebera YA, Sharma N.) Leuk Lymphoma. 2024 Nov;65(11):1698-1705 PMID: 38865104 06/12/2024

• In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy.

  (Dandoy CE, Adams J, Artz A, Bredeson C, Dahi PB, Dodd T, Jaglowski S, Lehmann L, LeMaistre CF, Mian A, Neal A, Page K, Rizzo JD, Rotz S, Sorror M, Steinberg A, Viswabandya A, Howard DS, Committee on Quality Outcomes of the American Society of Transplant and Cellular Therapy.) Transplant Cell Ther. 2024 Oct;30(10):942-954 PMID: 39067790 SCOPUS ID: 2-s2.0-85200735546 07/28/2024

• SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell Program.

  (Voorhees TJ, Bezerra E, Denlinger N, Jaglowski S, de Lima M.) Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):649-652 PMID: 38643029 04/21/2024

• Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.

  (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE.) Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 SCOPUS ID: 2-s2.0-85199289175 06/30/2024

• Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

  (Denlinger N, Song NJ, Zhang X, Jeon H, Peterson C, Wang Y, Reynolds K, Bolz RM, Miao J, Song C, Wu D, Chan WK, Bezerra E, Epperla N, Voorhees TJ, Brammer J, Kittai AS, Bond DA, Sawalha Y, Sigmund A, Reneau JC, Rubinstein MP, Hanel W, Christian B, Baiocchi RA, Maddocks K, Alinari L, Vasu S, de Lima M, Chung D, Jaglowski S, Li Z, Huang X, Yang Y.) Blood Adv. 2024 Jun 25;8(12):3140-3153 PMID: 38607381 PMCID: PMC11222947 04/12/2024

• Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

  (Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA.) J Clin Oncol. 2024 Jun 10;42(17):2071-2079 PMID: 38552193 03/29/2024

• A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.

  (Magenau J, Jaglowski S, Uberti J, Farag SS, Riwes MM, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun T, Devenport M, Lu S, Banerjee B, DaSilva C, Devine S, Zhang MJ, Burns LJ, Liu Y, Zheng P, Reddy P.) Blood. 2024 Jan 04;143(1):21-31 PMID: 37647633 PMCID: PMC10934299 SCOPUS ID: 2-s2.0-85173140340 08/30/2023

• Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.

  (Crees ZD, Rettig MP, Bashey A, Devine SM, Jaglowski S, Wan F, Zhou A, Harding M, Vainstein-Haras A, Sorani E, Gliko-Kabir I, Grossman BJ, Westervelt P, DiPersio JF, Uy GL.) Blood Adv. 2023 Sep 26;7(18):5210-5214 PMID: 37327120 PMCID: PMC10500469 06/16/2023

• Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability.

  (Ho VT, Klumpp TR, Liang WH, Prestegaard M, Horwitz M, Hamilton BK, Page K, Jaglowski S, Huber J, Martinez C, Shenoy V, Chen A, Rizzo D.) Transplant Cell Ther. 2023 Sep;29(9):539-547 PMID: 37379969 SCOPUS ID: 2-s2.0-85165030784 06/29/2023

• Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil.

  (Gray AN, Avila C, Chung CG, Seminario-Vidal L, Mims A, Dulmage B, Larkin K, Choe H, Jaglowski S, Vasu S, Kaffenberger BH.) JAAD Case Rep. 2023 Jun;36:82-88 PMID: 37250015 PMCID: PMC10220457 05/30/2023

• Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.

  (Chakraborty R, Yi J, Rybicki L, Preussler J, Deol A, Loren A, Savani B, Jim HSL, Cerny J, Reynolds J, Whitten J, Wingard JR, McGuirk JP, Uberti J, Khera N, Stiff P, Jaglowski SM, Hashmi S, Holtan SG, Devine S, Hahn T, Whalen VL, Saber W, Wood W, Baker KS, Syrjala K, Majhail NS.) Transplant Cell Ther. 2023 Jun;29(6):388.e1-388.e6 PMID: 36870388 PMCID: PMC10718487 SCOPUS ID: 2-s2.0-85153345405 03/05/2023

• A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

  (Hanel W, Shindiapina P, Bond DA, Sawalha Y, Epperla N, Voorhees T, Welkie RL, Huang Y, Behbehani GK, Zhang X, McLaughlin E, Chan WK, Brammer JE, Jaglowski S, Reneau JC, Christian BA, William BM, Cohen JB, Baiocchi RA, Maddocks K, Blum KA, Alinari L.) Cancers (Basel). 2023 Feb 24;15(5) PMID: 36900230 PMCID: PMC10000669 03/12/2023